Bionano Genomics, Inc. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
BNGO Nasdaq 8071 bionano.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bionano Genomics, Inc.

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption - Jun 18th, 2026 6:00 am
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - Jun 11th, 2026 6:00 am
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Jun 8th, 2026 10:00 am
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - May 28th, 2026 6:55 am
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures - May 28th, 2026 6:00 am
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia - May 26th, 2026 6:00 am
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder - May 20th, 2026 2:51 pm
Bionano Genomics, Inc. Q1 2026 Earnings Call Summary - May 14th, 2026 6:30 am
Bionano Genomics Inc (BNGO) Q1 2026 Earnings Call Highlights: Record Flow Cell Sales and ... - May 13th, 2026 11:02 pm
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates - May 13th, 2026 3:35 pm
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call - May 13th, 2026 3:10 pm
Bionano Reports First Quarter 2026 Results and Provides a Business Update - May 13th, 2026 2:05 pm
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates - May 12th, 2026 6:30 am
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1 - May 7th, 2026 6:50 am
Bionano Announces Leadership Transition - May 6th, 2026 2:30 pm
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 - May 5th, 2026 6:00 am
Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 - Apr 29th, 2026 2:05 pm
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - Apr 2nd, 2026 6:00 am
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... - Mar 23rd, 2026 9:00 pm
Bionano Genomics, Inc. Q4 2025 Earnings Call Summary - Mar 23rd, 2026 6:42 pm